n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® mPCR FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
HTT
Kit
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
QuantideX® NGS RNA Lung Cancer Kit
QuantideX® NGS DNA Hotspot 21 Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X
Leukemia
Dementia
Other Resources
Videos
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
About
Leadership Team
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Contact
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 22, 2018
New laboratory screening test for fragile X syndrome shortly after birth now ready for pivotal North Carolina Early Check clinical study
Share
October 16, 2018
Asuragen Announces New Commercial Leadership Appointment
Share
October 9, 2018
Asuragen to Present at 2018 American Society of Human Genetics Annual Meeting
Share
September 25, 2018
Asuragen to Host Panel at Upcoming World Clinical Biomarkers & Companion Diagnostic Summit
Share
September 5, 2018
Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit
Share
July 26, 2018
Asuragen Expands AmplideX® Technology and Product Line with Launch of PCR/CE SMN1 Kit
Share
May 22, 2018
Asuragen to Launch the AmplideX® PCR/CE
DMPK
Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference
Share
April 3, 2018
Asuragen to Present at 2018 ACMG Annual Clinical Genetics Meeting
Share
January 17, 2018
Asuragen Obtains CE Mark of QuantideX® qPCR BCR-ABL Kits on Roche Diagnostics cobas z 480 Analyzer
Share
November 21, 2017
Asuragen to Present at 29th Annual Piper Jaffray Healthcare Conference
Share
Prev
1
2
3
4
5
6
7
Next
About
About
Leadership Team
Board of Directors
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Back To
Top
